On the way to deprescribing levothyroxine in subclinical hypothyroidism in general practice – the patients’ perspective of enablers and barriers

Background Recent studies indicate that the synthetic thyroid hormone levothyroxine (LTX) in many cases has no beneficial effects on patients with subclinical hypothyroidism. Still, prescriptions are increasing worldwide. If there is no clear indication for treatment, patients treated with LTX shoul...

Full description

Bibliographic Details

Published in:	European Journal of General Practice
Main Authors:	M. Rennert, A. K. Geier, L. Christ, S. Hager, S. Scheibe, A. Rettich, J. Schübel, T. Deutsch, M. Bleckwenn, K. Voigt
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Subjects:	Deprescribing qualitative research patient involvement levothyroxine subclinical hypothyroidism
Online Access:	https://www.tandfonline.com/doi/10.1080/13814788.2025.2571605